| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2022 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 4 | Q3 2023 | 15.1% |
| VANGUARD TAX-MANAGED FDS | 4 | Q3 2023 | 10.8% |
| VANGUARD BD INDEX FDS | 4 | Q3 2023 | 9.9% |
| INVESCO EXCH TRADED FD TR II | 4 | Q3 2023 | 9.8% |
| VANGUARD INTL EQUITY INDEX F | 4 | Q3 2023 | 7.5% |
| ISHARES TR | 4 | Q3 2023 | 8.7% |
| ISHARES TR | 4 | Q3 2023 | 8.4% |
| ISHARES TR | 4 | Q3 2023 | 8.9% |
| AVALONBAY CMNTYS INC | 4 | Q3 2023 | 6.0% |
| ISHARES TR | 4 | Q3 2023 | 4.4% |
View Michelson Medical Research Foundation, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
View Michelson Medical Research Foundation, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.